PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “HEXOKINASE”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 487 records · Page 27Linked to original sources

Anomeric specificity of mammalian hexokinase.

The anomeric specificity of hexokinase was examined in crude homogenates of rat parotid gland, erythrocytes and pancreatic islets. At 8 degrees C, the alpha/beta ratio in maximal velocity averaged 0.73, 0.66 and 0.75 in the parotid, erythrocytes and pancreatic islets, respectively. Hexokinase displayed a greater affinity for alpha- than beta-D-glucose as judged from three criteria: the Km value, the reaction velocity measured with mixtures of the two anomers and their effect upon the phosphorylation of D-[U-14C] glucose in anomeric equilibrium. The latter procedure yielded an alpha/beta ratio in Km close to 0.51, 0.49 and 0.39 in parotid, erythrocytes and pancreatic islets, respectively. Within the limits of this study, the anomeric specificity of mammalian hexokinase would appear to be a mirror image of that of yeast hexokinase.

Animals↗

[Identification of hexokinase synthesizing polyribosomes in human normal and tumor tissues].

Comparative study of concentrations of growing hexokinase subunits polypeptide chains in the polyribosomes from normal and tumour human stomach tissue is studied using specific antiserum to hexokinase isoenzyme from human stomach tumour tissue. It is shown by two different methods (chromatography on Sepharose 46 and sucrose concentration gradient analysis) that the content of hexokinase polypeptides in stomach tumour is several times higher than in homologous normal tissue. The acta obtained show that the high activity of hexokinase in tumour tissues is due to the increased synthesis rate of the enzyme.

Hexokinase↗

[Subcellular localization, isoenzyme spectrum and properties of hexokinase from sarcoma M-1].

In sarcoma M-I the hexokinase activity was found to exceed three-fold the enzyme activity in muscular tissue. In the muscles and tumor intracellular distribution of hexokinase was essentially the same; the main part of the enzyme was localized in hyaloplasma. The mitochondrial hexokinase from sarcoma M-I was solubilized by considerably higher concentrations of KC1 (0.5 M), as compared with those required for the solubilization of the enzyme from muscular tissue (0.05 M). Studies of electrophoretic, kinetic properties and thermolability of the tumor enzyme demonstrated that only two hexokinase isoenzymes were found in sarcoma M-I hyaloplasm as compared with muscular tissue where isoenzymes I, II and IV were observed.

Animals↗

Dissimilar effects of D-mannoheptulose on the phosphorylation of alpha- versus beta-D-glucose by either hexokinase or glucokinase.

D-mannoheptulose inhibits D-glucose phosphorylation by hexokinase isoenzymes. The present study aims at investigating whether the pattern of such an inhibition differs in the case of alpha- versus beta-D-glucose. The phosphorylation of alpha- and beta-D-[U-14C]glucose was measured over 60-min incubation at 4 degrees C in the presence of bovine heart hexokinase and over 10 min at 24 degrees C in the presence of human liver glucokinase. The relative extent of the inhibitory action of D-mannoheptulose (0.02-10.0 mM) was always less marked with alpha- than beta-D-glucose. In the case of hexokinase, the experiments conducted at the high concentration of the D-glucose anomers (1.0 mM) revealed that D-mannoheptulose, at low concentrations (0.2-0.5 mM), may unexpectedly increase the phosphorylation of alpha-D-glucose. These findings thus document anomeric specificity in terms of the inhibitory action of D-mannoheptulose upon alpha- versus beta-D-glucose phosphorylation by either hexokinase or glucokinase.

Animals↗

Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.

BACKGROUND/AIMS: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been established as a powerful diagnosing modality in clinical oncology. FDG accumulation has been demonstrated to correlate with hexokinase activity. However, recent reports suggest that glucose transporters participate in FDG accumulation. The aim of this study is to evaluate glucose transporter and hexokinase expression and clarify the relationship between them and FDG accumulation. METHODOLOGY: FDG-PET was performed in 72 preoperative patients with esophageal cancer. The ratios of tumor radioactivity to plasma radioactivity (Ci/Cp values) were obtained 60 minutes after administration. We studied the expressions of glucose transporter 1 (Glut1) and type-II hexokinase (HK-II) by immunohistochemical analysis of the resected specimen. The percentages of cells expressing Glut1 and HK-II were scored on a 5-point scale (1=0-20%, 2=20-40%, 3=40-60%, 4=60-80%, 5=80-100%). Then the 3 scores obtained from 3 counting trials were averaged to give the Glut-index and HK-index. RESULTS: All esophageal cancers showed marked FDG accumulation. All 72 cancers expressed Glut1 and 71 of 72 cancers expressed HK-II. The Glut-index had a weak correlation with the Ci/Cp value (not significant). The HK-index had a close positive correlation with the Ci/Cp value (p<0.005). CONCLUSIONS: FDG accumulation correlates more with type-II hexokinase expression than with glucose transporter 1 expression.

Adult↗

The membrane-bound hexokinase as a potential marker for malignancy in human gliomas.

Hexokinase is a key enzyme in carbohydrate metabolism. Its activity has been shown elevated in cells with high mitotic index. In particular, experimental cancer cells, due to their peculiar energy metabolism, display a hexokinase activity proportional to the degree of malignancy. This is the case also for human gliomas in which glucose metabolism, evaluated via positron emission tomography, has been shown to be predictive for patient prognosis. In order to better correlate these findings, specific reagents for tumor hexokinase (a polyclonal antibody and a full-length cDNA probe both specific for murine tumor hexokinase) have been successfully employed to quantitate the protein and its messenger in cultured cell lines; the antibody was also tested in four specimens obtained from human astrocytomas.

Astrocytoma↗

[A study of hexokinase isoenzymes in rat sarcoma M-1].

Using a wide spectrum of criteria, the isozyme composition of hexokinase from sarcoma M-1 reinoculated to rat m. gastrocnemius was studied. The structural, physicochemical and functional properties of the homogeneous enzyme which is represented in sarcoma M-1 by one molecular form, were investigated. Some properties of the enzyme (amino acid composition, resistance to mild proteolysis, Mr, pH-dependence of enzyme activity, electrophoretic mobility, kinetic behaviour) indicate that sarcoma M-1 hexokinase is a specific form of the enzyme which differs markedly from other known isozymes of mammalian hexokinase. The observed peculiarities of sarcoma M-1 hexokinase are discussed in terms of present-day concepts on the structure of isozymic spectra of enzymes in neoplastic tissues.

Amino Acids↗

Brain hexokinase has no preexisting allosteric site for glucose 6-phosphate.

Difference spectroscopic investigations on the interaction of brain hexokinase with glucose and glucose 6-phosphate (Glc-6-P) show that the binary complexes E-glucose and E-Glc-6-P give very similar UV difference spectra. However, the spectrum of the ternary E-glucose-Glc-6-P complex differs markedly from the spectra of the binary complexes, but resembles that produced by the E-glucose-Pi complex. Direct binding studies of the interaction of Glc-6-P with brain hexokinase detect only a single high-affinity binding site for Glc-6-P (KD = 2.8 microM). In the ternary E-glucose-Glc-6-P complex, Glc-6-P has a much higher affinity for the enzyme (KD = 0.9 microM) and a single binding site. Ribose 5-phosphate displaces Glc-6-P from E-glucose-Glc-6-P only, but not from E-Glc-6-P complex. It also fails to displace glucose from E-glucose and E-glucose-Glc-6-P complexes. Scatchard plots of the binding of glucose to brain hexokinase reveal only a single binding site but show distinct evidence of positive cooperativity, which is abolished by Glc-6-P and Pi. These ligands, as well as ribose 5-phosphate, substantially increase the binding affinity of glucose for the enzyme. The spectral evidence, as well as the interactive nature of the sites binding glucose and phosphate-bearing ligands, lead us to conclude that an allosteric site for Glc-6-P of physiological relevance occurs on the enzyme only in the presence of glucose, as a common locus where Glc-6-P, Pi, and ribose 5-phosphate bind. In the absence of glucose, Glc-6-P binds to the enzyme at its active site with high affinity. We also discuss the possibility that, in the absence of glucose, Glc-6-P may still bind to the allosteric site, but with very low affinity, as has been observed in studies on the reverse hexokinase reaction.

Adenosine Triphosphate↗

Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP.

Previous studies from this laboratory have shown that mitochondrial bound hexokinase is markedly elevated in highly glycolytic hepatoma cells (Parry, D. M., and Pedersen, P.L. (1983) J. Biol. Chem. 258, 10904-10912). A pore-forming protein, porin, within the outer membrane appears to comprise at least part of the receptor site (Nakashima, R.A., Mangan, P.S., Colombini, M., and Pedersen, P.L. (1986). Biochemistry 25, 1015-1021). In studies reported here experiments were carried out to assess the functional significance of mitochondrial bound tumor hexokinase. Two approaches were used to determine whether the bound enzyme has preferred access to mitochondrially generated ATP relative to cytosolic ATP. The first approach compared the time course of glucose 6-phosphate formation by AS-30D hepatoma mitochondria under conditions where ATP was regenerated endogenously via oxidative phosphorylation or exogenously by added pyruvate kinase and phosphoenolpyruvate. The second approach involved the measurement of the specific radioactivity of glucose 6-phosphate formed following the addition of [gamma-32P]ATP to either phosphorylating or nonphosphorylating AS-30D mitochondria. Both approaches provided results which show that the source of ATP for bound hexokinase is derived preferentially from the ATP synthase residing within the inner mitochondrial membrane compartment rather than from the medium (i.e. from the cytosolic compartment). These results provide the first direct demonstration that the exceptionally high level of hexokinase bound to mitochondria of highly glycolytic tumor cells has preferred access to mitochondrially generated ATP, a finding that may have rather profound metabolic significance for such tumors.

Adenosine Triphosphate↗

The complete amino acid sequence of the catalytic domain of rat brain hexokinase, deduced from the cloned cDNA.

The complete amino acid sequence of the catalytic domain of rat brain hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) has been deduced from the nucleotide sequence of cloned cDNA. Extensive similarity in sequence, taken to indicate similarity in secondary and tertiary structure, is seen between the mammalian enzyme and yeast hexokinase isozymes A and B. All residues critical for binding glucose to the yeast enzyme are conserved in brain hexokinase. A location for the substrate ATP binding site is proposed based on relation of structural features in the yeast enzyme to characteristics commonly observed in other nucleotide binding enzymes; sequences in regions proposed to be important for binding of ATP to the yeast enzyme are highly conserved in brain hexokinase.

Adenosine Monophosphate↗

Subcellular distribution of hexokinase in leukemic and stimulated lymphoid cells of mice.

The oxygen consumption, subcellular distribution of hexokinase were studied in normal and leukemic spleen cells of AKR mice. High mitochondrial-bound hexokinase activity and O2-consumption were detected in fetal state, in leukemic or BPV-induced lymphoproliferative conditions and after spermine incubation of normal spleen cells. After ConA-treatment, however, all of the hexokinase was found in cytoplasmic fraction and O2-uptake was strongly decreased. Studies on respiration of mitochondria isolated from normal and leukemic cells supported the role of mitochondrial-bound hexokinase in elevated O2-consumption of leukemic cells.

Aging↗

Changes in hexokinase isoenzymes in regions of rat brain during thyroid deficiency.

In this work, activities of hexokinase isoenzymes Type I and Type II were measured in the soluble and particulate fractions from the brain regions (cerebral hemispheres (cerebrum), cerebellum and brain stem) of the thyroidectomized adult rats as well as of the thyroidectomized rats administered with triiodothyronine. Thyroidectomy generally decreased the hexokinase activity associated with particulate and soluble fractions. Hexokinase Type II isoenzyme was more affected than the Type I isoenzyme. Administration of triiodothyronine to the hypothyroid rats abolished the effect of thyroidectomy. Adult brain enzymes have been generally considered not be affected by thyroid hormones. The data obtained in this work are suggestive of an effect of thyroid hormones on hexokinase in the adult brain. Since the effects of thyroidectomy on the energy metabolism of the heart tissue are well known, the heart tissue was also studied for comparison.

Animals↗

[The role of bivalent cations in the binding of hexokinase II isoenzyme to mitochondrial membranes].

A comparative study of Mg2+ and Ca2+ effects on the ability of rat skeletal muscle hexokinase isozyme II to bind mitochondrial membranes isolated from the same source was carried out. It was found that the binding ability of the enzyme increases in a similar way in the presence of equimolar amounts of both cations. The dependence of binding ability on cation concentration is hyperbolic, which points to the existence of specific and equivalent metal binding sites during hexokinase attachment to the membranes. Substitution of Ca2+ for Mg2+ does not influence the tightness of the enzyme binding to membranes, which can be evidenced from the type of dependence of the bound hexokinase solubilization degree on KCl concentration in the eluting buffer. The enzyme absorption mediated by various cations is accompanied by corresponding changes in its kinetic properties (V, Km for glucose, Ki for ADP). The role of bivalent cations in the formation of the specific hexokinase-membrane binding is discussed.

Animals↗

[Sensitivity of hexokinase and glucokinase to hormonal action during hepatocarcinogenesis].

Effects of hydrocortisone and insulin on activities of hexokinase and its isoenzymes and on glucokinase activity were studied in hepatocarcinogenesis, induced in rats by diethyl nitrosamine. After administration during 7 days of hydrocortisone into normal rats the hexokinase was inactivated by 25% due to decrease in activity of the II isoenzyme. In this case activity of glucokinase was decreased by 38% in young animals and--by 23% in older animals. Insulin, administered within 2 days, caused no effect on the hexokinase activity but the glucokinase was activated by 177%. In hepatocarcinogenesis the effect of hydrocortisone on the hexokinase activity (II isoenzyme) was distinctly decreased and with development of tumors the hormone showed a negligible efficiency. Influence of insulin on the glucokinase activity in hepatocarcinogenesis was similar to the effect found in normal liver tissue.

Animals↗

Mammalian hexokinases: a system for the study of co-operativity in monomeric enzymes.

Kinetic and structural studies have been carried out of two isoenzymes of hexokinase from the rat, hexokinase II and glucokinase. Although both enzymes are monomeric, hexokinase II has a molecular weight double that of glucokinase and resembles a dimer of glucokinase. The co-operativity of glucokinase, which is not observed for hexokinase II, appears to be kinetic in origin rather than the consequence of ineractions between distinct glucose-binding sites.

Animals↗

[Effect of cAMP on hexokinase and glucose-6-phosphate dehydrogenase isoenzymes in different white rat tissues].

Preincubation of liver and skeletal muscle cytosol obtained from Wistar rats in the presence of cAMP, ATP and MgCl2 inhibited hexokinase. The decrease in the total enzymatic activity was a consequence of inhibition of types 2 and 3 hexokinase. The activity of type 1 hexokinase was unchanged. Under the similar conditions there was a lowering of the total activity of glucose-6-phosphate dehydrogenase which arose from inhibition of types 1 and 2 of the enzyme. The activity of other glucose-6-phosphate dehydrogenase isozymes remained unchanged. Preincubation of adrenal supernatant with cAMP, ATP and MgCl2 did not alter the activity of both enzymes. This is likely to be due to the absence of the respective cAMP-dependent proteinkinases and to the features of the isozyme spectrum. The results obtained indicate that hexokinase and glucose-6-phosphate dehydrogenase can be attributed to the group of enzymes that are regulated by the "phosphorylation-dephosphorylation" mechanism.

Adenosine Triphosphate↗

Hexokinase of calf trabecular meshwork.

Although aqueous outflow is most likely a passive, nonenergy-dependent process, alterations in cellular function in the trabecular meshwork presumably are involved in the development of some types of glaucoma. Accordingly, it seems important to define both the normal and abnormal biochemistry of this tissue. The authors have chosen glycolysis as their starting point, concentrating on the regulatory enzymes, hexokinase, and, in a companion paper, phosphofructokinase. Hexokinase activity has been measured in the 100,000 X g supernatant of homogenates prepared from excised calf trabecular meshwork. Treatment of the homogenate with Triton X-100 before centrifuging caused a twofold increase in measurable activity. Electrophoresis on cellulose acetate revealed types I and II isoenzymes. Electrophoresis on starch gel further resolved type 1 into the adult and fetal subtypes. The principal isoenzyme type released into solution by Triton X-100 was type 1. The kinetic behavior of hexokinase was measured by varying the concentrations of glucose at saturating levels of ATP. Kms calculated from these plots were 7.15 X 10(-2) M, 1.78 X 10(-3) M, and 1.19 X 10(-4) M. Apart from the fetal form of type I hexokinase, the isoenzymes from trabecular meshwork resemble those of other ocular tissues and most extraocular tissues. The special role, if any, of the fetal isoenzyme in regulating glycolysis is not known. Possibly, it is a "kinetically adaptable" isoenzyme.

Animals↗

Divalent cation-dependent stereospecificity of adenosine 5'-O-(2-thiotriphosphate) in the hexokinase and pyruvate kinase reactions. The absolute stereochemistry of the diastereoisomers of adenosine 5'-O-(2-thiotriphosphate).

31P NMR studies with Cd(II) and Zn(II) chelates of adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS) and the Cd(II) chelate of adenosine 5'-O-(2-thiotriphosphate) (ATPbetaS) indicate that these metal ions chelate to the sulfur atom of the thiophosphate group. Since Mg(II) chelates to oxygen of the thiophosphate group of diastereoisomer is equivalent to the configuration of the Cd(II) chelate of the opposite diastereoisomer. As a consequence, an inversion of the stereospecificity is observed when Cd(II) is substituted for Mg(II) in the phosphoryl transfer reactions catalyzed by yeast hexokinase and rabbit muscle pyruvate kinase. When Co(II) is the activating ion for yeast hexokinase with ATPbetaS as substrate, no stereospecificity is observed. Since the absolute configuration for the diastereoisomer of Co(III)(NH3)4ATP which is the active substrate for yeast hexokinase has been established by Cornelius and Cleland (Cornelius, R. D., and Cleland, W. W. (1978) Biochemistry, in press), the absolute stereochemistry of the Mg(II) complex of the B isomer of ATPbetaS is now established by its stereospecificity in the hexokinase reaction.

Adenosine Triphosphate↗